Routines, food habits and follow-up discipline — quietly reinforced.
Improving treatment outcomes with care
New medicines work better when patients feel supported.
Riteven holds patients steady through diabetes care, GLP-1 treatment and novel therapies — the everyday parts of getting better that a clinic visit can’t always cover.
● Private
● Doctor-aligned
● Made for Indian patients
Day 3 check-in
“How are you feeling after starting?”
Doctor-first
Medical concerns are routed back to the treating doctor.
Adherence up · Anxiety down
Support through appetite shifts, nausea concerns and meal changes.
Extra care when treatment is high-value, complex or new to the patient.
For patients and caregivers
Fortifying your journey after the prescription.
Many patients leave the clinic with medicine, but still have questions at home. What should I eat? Is this discomfort normal? What if I miss a dose? When should I call my doctor?
Riteven is a calm support layer between doctor visits — so treatment feels easier to continue.
What patients usually ask us
Food & appetite changes
Nausea, fatigue or discomfort
Missed-dose confusion
Motivation dips
Trigger prescribing doctor visits
When to call the doctor
Built with medical oversight
Novel care positioning
Modern treatments need modern support.
GLP-1 medicines, biologics, monoclonal antibodies and other advanced therapies are often high-value and early in the patient journey. A leaflet is not enough. Patients need clear routines, reassurance — with the doctor kept at the centre.
Beyond-the-pill supportPractical help after the prescription. Never a replacement for the doctor.
Digital touchpointsSimple follow-ups on call, WhatsApp and email.
Adherence & safetyCheck-ins that keep patients going while raising concerns early.
Personalised careBased on the patient’s actual journey — not one fixed script.
What Riteven takes care of
Four support layers patients can feel.
Simple care actions that make treatment less confusing and easier to continue.
Adherence
Medicine reminders, dose-day check-ins, refill prompts and missed-routine follow-up.
Digital engagement
Low-friction patient communication through familiar, everyday channels.
Emotional support
Counselling for stress, hesitation, treatment fatigue and motivation dips.
Nutrition regimens
Practical Indian meal guidance for appetite, hydration, protein, fibre and portions.
Diabetes and GLP-1 journeys
The first few weeks decide a lot.
With diabetes and GLP-1 treatments, patients often need help reading appetite changes, nausea, meal timing, hydration and follow-up discipline. Riteven keeps the journey simple, practical and doctor-aligned.
- Explain what changes may happen early
- Help patients build a daily routine
- Support nutrition and hydration habits
- Guide patients back to the doctor when needed
Riteven · Check-in
10:24
I started treatment this week. I feel full very quickly.
That can happen. Let’s focus on smaller meals, hydration and protein. If discomfort continues or worsens, we’ll loop in your doctor.
Can you remind me about follow-up?
Yes — I’ll ping you a day before. You’re doing great 🌿
How it works
Simple for patients. Responsible for doctors.
Patient shares details
Basic treatment context, doctor details and the support needed.
Support need is mapped
Routine, nutrition, counselling, digital engagement or follow-up support.
Care touchpoints begin
Patients get structured support in a calm, non-overwhelming way.
Doctor remains central
Medical questions and concerning symptoms are routed back to the doctor.
Privacy-first support
Patients should feel safe asking for help.
Riteven uses consent-led communication, limited data collection and restricted access. Support is designed to feel respectful, confidential and aligned with the patient’s doctor.
100%Consent-led
0Shared with advertisers
24/7Revoke anytime
For pharma partners
Patient support for high-value treatment journeys.
Riteven offers pharma teams a patient-first PSP layer for diabetes, GLP-1 and novel medicines. The aim is clear: better continuity, more confident patients, happier doctors and stronger outcomes.
Adherence
Structured routines, reminders and refill behaviour.
Digital Connect
Low-friction engagement through familiar channels.
Emotional Counselling
Confidence, stress and motivation support.
Nutrition Regimens
Practical regimens patients realistically follow.
Results that pharma teams care about
PSP success, measured where it matters.
Numbers pulled from programs built on the Riteven framework — focused on conversion, continuation and confidence.
69%
Adherence at Day 90
Patients still on therapy after three months of structured Riteven touchpoints.
1.9x
Follow-up retention
Lift in patients returning for their next doctor visit vs. unsupported cohorts.
68%
Lower treatment anxiety
Patients reported reduced side-effect worry within the first four weeks.
4.7/5
Patient CSAT
Average satisfaction across diabetes and GLP-1 cohorts over the last 12 months.
<24h
First touchpoint
Median time from patient enrolment to the first real Riteven conversation.
91%
Consent-led continuation
Patients who chose to continue the program at the end of their first cycle.
Start with Riteven
Choose the right form.
Patients can request support. Pharma teams can share PSP requirements.
Patient support request
For diabetes care, GLP-1 treatment, medicine routine, nutrition, counselling or follow-up support.
Pharma PSP enquiry
For healthcare and pharma teams exploring patient support programs for diabetes, GLP-1 therapies and chronic care.
The people behind Riteven
Clinicians, scientists and a builder who’s done this before.
A small team with deep clinical credibility and real-world healthcare execution experience.
Dr Raju M R
Family Physician · Diabetes Specialist · Angel Investor · Pharma Innovator
Dr. Raju anchors Riteven’s clinical governance, helping shape doctor-aligned support protocols for diabetes, GLP-1 and novel medicine journeys. His role is to keep patient support medically responsible from adherence guidance and symptom escalation to treatment-continuity workflows that keep the treating doctor at the centre. He has previously worked with global healthcare organisations including Pfizer, AstraZeneca and Menarini, contributing to clinical programs focused on metabolic disease care.
- 15+ years clinical experience
- Clinical governance for patient-support programs
- 200+ directly supervised GLP-1 patients
- Published in international medical journals
Dr Gunjan Lath
Clinical Nutrition Specialist · Metabolic Health · Obesity & Diabetes Care
Dr. Gunjan Lath is a Medical Affairs and clinical nutrition leader with 15+ years of experience across pharma, nutrition, medical devices, and digital health. With prior experience at Abbott and AstraZeneca, she has worked extensively in diabetes, obesity, critical care nutrition, and metabolic disease care, bringing strong expertise in medical governance, patient education, compliance, and evidence-based care programs.
- 15+ years clinical experience
- Experience in patient support programs and SOPs
- Worked with Abbott and AstraZeneca
- Moderator across 3000+ CMEs and advisory boards
Vikash Kumar
Founder & CEO · Hilt Brands (Bibo.Health) · Healthcare Builder
Vikash is the founder of Hilt Brands, the Bengaluru-based consumer healthcare company behind Bibo.Health, Dr. Motabhai and Riteven. An IIT alumnus with 10+ years across investment banking — Deloitte, SBICaps and Springforth Capital — advising pharma, healthcare and energy deals, he launched Hilt Brands to build science-first, digitally-native healthcare platforms for under-served therapy journeys in India.
- Founder · Hilt Brands · Bibo.Health · Dr. Motabhai
- IIT-BHU & IIT Kharagpur alumnus
- 10+ years in healthcare & pharma finance
- Backed by AH Ventures · seed round 2022